Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Awake thyroidectomy.

Haugen TW, Andera LN, LaMadrid AB.

Laryngoscope. 2019 Jul 30. doi: 10.1002/lary.28196. [Epub ahead of print]

PMID:
31361327
2.

Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma.

Prukova D, Andera L, Nahacka Z, Karolova J, Svaton M, Klanova M, Havranek O, Soukup J, Svobodova K, Zemanova Z, Tuskova D, Pokorna E, Helman K, Forsterova K, Pacheco-Blanco M, Vockova P, Berkova A, Fronkova E, Trneny M, Klener P.

Clin Cancer Res. 2019 Jul 15;25(14):4455-4465. doi: 10.1158/1078-0432.CCR-18-3275. Epub 2019 Apr 19.

PMID:
31004002
3.

Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2.

Hubackova S, Davidova E, Rohlenova K, Stursa J, Werner L, Andera L, Dong L, Terp MG, Hodny Z, Ditzel HJ, Rohlena J, Neuzil J.

Cell Death Differ. 2019 Jan;26(2):276-290. doi: 10.1038/s41418-018-0118-3. Epub 2018 May 21.

4.

Induction, regulation and roles of neural adhesion molecule L1CAM in cellular senescence.

Mrazkova B, Dzijak R, Imrichova T, Kyjacova L, Barath P, Dzubak P, Holub D, Hajduch M, Nahacka Z, Andera L, Holicek P, Vasicova P, Sapega O, Bartek J, Hodny Z.

Aging (Albany NY). 2018 Mar 28;10(3):434-462. doi: 10.18632/aging.101404.

5.

Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP.

Piggott L, Silva A, Robinson T, Santiago-Gómez A, Simões BM, Becker M, Fichtner I, Andera L, Young P, Morris C, Barrett-Lee P, Alchami F, Piva M, Vivanco MD, Clarke RB, Gee J, Clarkson R.

Clin Cancer Res. 2018 May 15;24(10):2452-2463. doi: 10.1158/1078-0432.CCR-17-1381. Epub 2018 Jan 23.

6.

TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.

Nahacka Z, Svadlenka J, Peterka M, Ksandrova M, Benesova S, Neuzil J, Andera L.

Biochim Biophys Acta Mol Cell Res. 2018 Mar;1865(3):522-531. doi: 10.1016/j.bbamcr.2017.12.006. Epub 2017 Dec 24.

7.

Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10.

Vondálová Blanářová O, Šafaříková B, Herůdková J, Krkoška M, Tománková S, Kahounová Z, Anděra L, Bouchal J, Kharaishvili G, Král M, Sova P, Kozubík A, Hyršlová Vaculová A.

PLoS One. 2017 Nov 28;12(11):e0188584. doi: 10.1371/journal.pone.0188584. eCollection 2017.

8.

Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells.

Dong LF, Kovarova J, Bajzikova M, Bezawork-Geleta A, Svec D, Endaya B, Sachaphibulkij K, Coelho AR, Sebkova N, Ruzickova A, Tan AS, Kluckova K, Judasova K, Zamecnikova K, Rychtarcikova Z, Gopalan V, Andera L, Sobol M, Yan B, Pattnaik B, Bhatraju N, Truksa J, Stopka P, Hozak P, Lam AK, Sedlacek R, Oliveira PJ, Kubista M, Agrawal A, Dvorakova-Hortova K, Rohlena J, Berridge MV, Neuzil J.

Elife. 2017 Feb 15;6. pii: e22187. doi: 10.7554/eLife.22187.

9.

Manipulating Wnt signaling at different subcellular levels affects the fate of neonatal neural stem/progenitor cells.

Kriska J, Honsa P, Dzamba D, Butenko O, Kolenicova D, Janeckova L, Nahacka Z, Andera L, Kozmik Z, Taketo MM, Korinek V, Anderova M.

Brain Res. 2016 Nov 15;1651:73-87. doi: 10.1016/j.brainres.2016.09.026. Epub 2016 Sep 19.

PMID:
27659965
10.

A novel analytical method for d-glucosamine quantification and its application in the analysis of chitosan degradation by a minimal enzyme cocktail.

Mekasha S, Toupalová H, Linggadjaja E, Tolani HA, Anděra L, Arntzen MØ, Vaaje-Kolstad G, Eijsink VG, Agger JW.

Carbohydr Res. 2016 Oct 4;433:18-24. doi: 10.1016/j.carres.2016.07.003. Epub 2016 Jul 4.

PMID:
27423879
11.

Multifunctional adaptor protein Daxx interacts with chromatin-remodelling ATPase Brg1.

Svadlenka J, Brazina J, Hanzlikova H, Cermak L, Andera L.

Biochem Biophys Rep. 2015 Dec 30;5:246-252. doi: 10.1016/j.bbrep.2015.12.012. eCollection 2016 Mar.

12.

Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma.

Klanova M, Andera L, Brazina J, Svadlenka J, Benesova S, Soukup J, Prukova D, Vejmelkova D, Jaksa R, Helman K, Vockova P, Lateckova L, Molinsky J, Maswabi BC, Alam M, Kodet R, Pytlik R, Trneny M, Klener P.

Clin Cancer Res. 2016 Mar 1;22(5):1138-49. doi: 10.1158/1078-0432.CCR-15-1191. Epub 2015 Oct 14. Erratum in: Clin Cancer Res. 2016 Aug 1;22(15):3984.

13.

DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase.

Brazina J, Svadlenka J, Macurek L, Andera L, Hodny Z, Bartek J, Hanzlikova H.

Cell Cycle. 2015;14(3):375-87. doi: 10.4161/15384101.2014.988019.

14.

CGP74514A enhances TRAIL-induced apoptosis in breast cancer cells by reducing X-linked inhibitor of apoptosis protein.

Park S, Shim SM, Nam SH, Andera L, Suh N, Kim I.

Anticancer Res. 2014 Jul;34(7):3557-62.

PMID:
24982369
15.

Biosynthesis of colabomycin E, a new manumycin-family metabolite, involves an unusual chain-length factor.

Petříčková K, Pospíšil S, Kuzma M, Tylová T, Jágr M, Tomek P, Chroňáková A, Brabcová E, Anděra L, Krištůfek V, Petříček M.

Chembiochem. 2014 Jun 16;15(9):1334-45. doi: 10.1002/cbic.201400068. Epub 2014 May 18.

PMID:
24838618
16.

Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.

Han Y, Park S, Kinyua AW, Andera L, Kim KW, Kim I.

Oncol Rep. 2014 Jan;31(1):456-62. doi: 10.3892/or.2013.2838. Epub 2013 Nov 7.

PMID:
24213797
17.

Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins.

Park S, Cho DH, Andera L, Suh N, Kim I.

Mol Cell Biochem. 2013 Nov;383(1-2):39-48. doi: 10.1007/s11010-013-1752-1. Epub 2013 Jul 12.

PMID:
23846485
18.

Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.

Vinarsky V, Krivanek J, Rankel L, Nahacka Z, Barta T, Jaros J, Andera L, Hampl A.

Stem Cells Dev. 2013 Nov 15;22(22):2964-74. doi: 10.1089/scd.2013.0057. Epub 2013 Aug 2.

19.

Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.

Horova V, Hradilova N, Jelinkova I, Koc M, Svadlenka J, Brazina J, Klima M, Slavik J, Hyrslova Vaculova A, Andera L.

FEBS J. 2013 Jul;280(14):3436-50. doi: 10.1111/febs.12347. Epub 2013 Jun 18.

20.

Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling.

Kaminskyy VO, Surova OV, Piskunova T, Zborovskaya IB, Tchevkina EM, Andera L, Zhivotovsky B.

Cell Death Dis. 2013 Mar 7;4:e522. doi: 10.1038/cddis.2013.51.

21.

The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms.

Beranova L, Pombinho AR, Spegarova J, Koc M, Klanova M, Molinsky J, Klener P, Bartunek P, Andera L.

Apoptosis. 2013 Jun;18(6):739-50. doi: 10.1007/s10495-013-0823-9.

PMID:
23456623
22.

Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL).

Leahomschi S, Molinsky J, Klanova M, Andera L, Peterka M, Gasova Z, Klener P Sr, Trneny M, Necas E, Simonova T, Zivny J, Klener P Jr.

Neoplasma. 2013;60(2):223-31.

PMID:
23259793
23.

TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis.

Somasekharan SP, Koc M, Morizot A, Micheau O, Sorensen PH, Gaide O, Andera L, Martinou JC.

Apoptosis. 2013 Mar;18(3):324-36. doi: 10.1007/s10495-012-0782-6.

PMID:
23179179
24.

Roscovitine sensitizes leukemia and lymphoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

Molinsky J, Klanova M, Koc M, Beranova L, Andera L, Ludvikova Z, Bohmova M, Gasova Z, Strnad M, Ivanek R, Trneny M, Necas E, Zivny J, Klener P.

Leuk Lymphoma. 2013 Feb;54(2):372-80. doi: 10.3109/10428194.2012.710331. Epub 2012 Sep 8.

PMID:
22830613
25.

Sensitization of (colon) cancer cells to death receptor related therapies: a report from the FP6-ONCODEATH research consortium.

Pintzas A, Zhivotovsky B, Workman P, Clarke PA, Linardopoulos S, Martinou JC, Lacal JC, Robine S, Nasioulas G, Andera L.

Cancer Biol Ther. 2012 May;13(7):458-66. doi: 10.4161/cbt.19600. Epub 2012 May 1. Review.

PMID:
22406997
26.

BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.

Makrodouli E, Oikonomou E, Koc M, Andera L, Sasazuki T, Shirasawa S, Pintzas A.

Mol Cancer. 2011 Sep 23;10:118. doi: 10.1186/1476-4598-10-118.

27.

Selective BRAFV600E inhibitor PLX4720, requires TRAIL assistance to overcome oncogenic PIK3CA resistance.

Oikonomou E, Koc M, Sourkova V, Andera L, Pintzas A.

PLoS One. 2011;6(6):e21632. doi: 10.1371/journal.pone.0021632. Epub 2011 Jun 27.

28.

T-cell activation triggers death receptor-6 expression in a NF-κB and NF-AT dependent manner.

Klíma M, Broučková A, Koc M, Anděra L.

Mol Immunol. 2011 Jul;48(12-13):1439-47. doi: 10.1016/j.molimm.2011.03.021. Epub 2011 Apr 17.

PMID:
21501873
29.

MAC'09, Otto and us….

Neuzil J, Andera L, Kozubik A.

Mitochondrion. 2010 Nov;10(6):583. doi: 10.1016/S1567-7249(10)00171-6. No abstract available.

PMID:
21056400
30.

Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.

Vondálová Blanárová O, Jelínková I, Szöor A, Skender B, Soucek K, Horváth V, Vaculová A, Andera L, Sova P, Szöllosi J, Hofmanová J, Vereb G, Kozubík A.

Carcinogenesis. 2011 Jan;32(1):42-51. doi: 10.1093/carcin/bgq220. Epub 2010 Oct 29.

PMID:
21037225
31.

The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies.

Zivny J, Klener P Jr, Pytlik R, Andera L.

Curr Pharm Des. 2010 Jan;16(1):11-33. Review.

PMID:
20214615
32.

Signaling activated by the death receptors of the TNFR family.

Andera L.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Sep;153(3):173-80. Review.

33.

Functional analysis of the posttranslational modifications of the death receptor 6.

Klíma M, Zájedová J, Doubravská L, Andera L.

Biochim Biophys Acta. 2009 Oct;1793(10):1579-87. doi: 10.1016/j.bbamcr.2009.07.008. Epub 2009 Aug 3.

34.

TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors.

Oikonomou E, Kosmidou V, Katseli A, Kothonidis K, Mourtzoukou D, Kontogeorgos G, Andera L, Zografos G, Pintzas A.

Int J Cancer. 2009 Nov 1;125(9):2127-35. doi: 10.1002/ijc.24613.

35.

Future use of mitocans against tumour-initiating cells?

Morrison BJ, Andera L, Reynolds BA, Ralph SJ, Neuzil J.

Mol Nutr Food Res. 2009 Jan;53(1):147-53. doi: 10.1002/mnfr.200800254. Review.

PMID:
19123176
36.

TRAIL-induced apoptosis of HL60 leukemia cells: two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNFalpha but not to idarubicin and cytarabine.

Klener P Jr, Leahomschi S, Molinsky J, Simonova T, Necas E, Gasova Z, Cermak J, Dolezalova L, Andera L, Zivny J.

Blood Cells Mol Dis. 2009 Jan-Feb;42(1):77-84. doi: 10.1016/j.bcmd.2008.10.002. Epub 2008 Nov 26.

PMID:
19038561
37.

Culture of primary epithelial adenoma cells from familial adenomatous polyposis patients.

Fostira F, Apessos A, Oikonomou E, Kouklis P, Baratsis S, Manifikos G, Andera L, Yannoukakos D, Pintzas A, Nasioulas G.

Anticancer Res. 2008 Mar-Apr;28(2A):843-6.

38.

Wnt-expressing rat embryonic fibroblasts suppress Apo2L/TRAIL-induced apoptosis of human leukemia cells.

Doubravská L, Símová S, Cermak L, Valenta T, Korínek V, Andera L.

Apoptosis. 2008 Apr;13(4):573-87. doi: 10.1007/s10495-008-0191-z. Epub 2008 Mar 18.

PMID:
18347988
39.

Arf and Rho GAP adapter protein ARAP1 participates in the mobilization of TRAIL-R1/DR4 to the plasma membrane.

Símová S, Klíma M, Cermak L, Sourková V, Andera L.

Apoptosis. 2008 Mar;13(3):423-36. doi: 10.1007/s10495-007-0171-8.

PMID:
18165900
40.

LFA-1-mediated leukocyte adhesion regulated by interaction of CD43 with LFA-1 and CD147.

Khunkaewla P, Schiller HB, Paster W, Leksa V, Cermák L, Andera L, Horejsí V, Stockinger H.

Mol Immunol. 2008 Mar;45(6):1703-11. Epub 2007 Nov 9.

PMID:
17996943
41.

Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts.

Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A.

Mol Cancer Ther. 2007 Sep;6(9):2591-9.

42.

Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo.

Oikonomou E, Kothonidis K, Taoufik E, Probert E, Zografos G, Nasioulas G, Andera L, Pintzas A.

Br J Cancer. 2007 Jul 2;97(1):73-84. Epub 2007 Jun 5. Erratum in: Br J Cancer. 2007 Dec 17;97(12):1716. Taoufik,E [added]; Probert, E [added].

43.

Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?

Neuzil J, Stantic M, Zobalova R, Chladova J, Wang X, Prochazka L, Dong L, Andera L, Ralph SJ.

Biochem Biophys Res Commun. 2007 Apr 20;355(4):855-9. Epub 2007 Feb 6. Review.

PMID:
17307142
44.

Cell death signalling pathways in the pathogenesis and therapy of haematologic malignancies: overview of therapeutic approaches.

Klener P Jr, Andera L, Klener P, Necas E, Zivný J.

Folia Biol (Praha). 2006;52(4):119-36. Review.

45.

Cell death signalling pathways in the pathogenesis and therapy of haematologic malignancies: overview of apoptotic pathways.

Klener P Jr, Andera L, Klener P, Necas E, Zivný J.

Folia Biol (Praha). 2006;52(1-2):34-44. Review.

46.

Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: implication for sensitisation of resistant cancer cells to TRAIL apoptosis.

Tomasetti M, Andera L, Alleva R, Borghi B, Neuzil J, Procopio A.

FEBS Lett. 2006 Apr 3;580(8):1925-31. Epub 2006 Feb 28.

47.

TRAIL and docosahexaenoic acid cooperate to induce HT-29 colon cancer cell death.

Vaculová A, Hofmanová J, Andera L, Kozubík A.

Cancer Lett. 2005 Nov 8;229(1):43-8. Epub 2005 Jan 18.

PMID:
16157217
48.
49.

Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.

Drosopoulos KG, Roberts ML, Cermak L, Sasazuki T, Shirasawa S, Andera L, Pintzas A.

J Biol Chem. 2005 Jun 17;280(24):22856-67. Epub 2005 Mar 8.

50.

Ethanol acts as a potent agent sensitizing colon cancer cells to the TRAIL-induced apoptosis.

Vaculová A, Hofmanová J, Soucek K, Andera L, Kozubík A.

FEBS Lett. 2004 Nov 5;577(1-2):309-13.

Supplemental Content

Loading ...
Support Center